Onderneming Abbott Laboratories
Aandelen
ABT
US0028241000
Medische apparatuur, benodigdheden & distributie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
130,27 USD | -0,26% |
|
-1,02% | +15,02% |
11/02 | Edwards Lifesciences overtreft winstraming op kracht in hartapparaten | RE |
03/02 | Abbott Laboratories Insider verkocht aandelen ter waarde van $3.054.574, volgens een recente SEC filing | MT |
Beschrijving van de bedrijfsactiviteiten: Abbott Laboratories
- diagnosesystemen en -instrumenten (39,1%);
- voorzieningen voor de bloedvaten (24,7%): endoprothesesystemen, dilatatiekatheters, sluiting van bloedvaten , enz.;
- voedingsproducten (12,1%): producten voor kindervoeding, voedingssupplementen en dieetproducten;
- medicijnen (8,2%): verdovende, antivirale, antibiotische, inhiberende, ontstekingremmende producten, enz.;
- overige (15,9%).
De geografische verdeling van de omzet is als volgt: Verenigde Staten (38,5%), Duitsland (5,8%), China (5,6%), India (4,4%), Zwitserland (4,1%), Japan (3,8%), Nederland (2,7%) en overige (35,1%).
Aantal werknemers: 114 000
Verdeling van verkoop per activiteit: Abbott Laboratories
Start boekjaar: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Medical Devices | 12,24 mld. | 11,79 mld. | 14,37 mld. | 14,69 mld. | 16,89 mld. |
Diagnostics | 7,71 mld. | 10,8 mld. | 15,64 mld. | 16,58 mld. | 9,99 mld. |
Nutrition | 7,41 mld. | 7,65 mld. | 8,29 mld. | 7,46 mld. | 8,15 mld. |
Established Pharmaceutical | 4,49 mld. | 4,3 mld. | 4,72 mld. | 4,91 mld. | 5,07 mld. |
Other | 57 mln. | 66 mln. | 52 mln. | 11 mln. | 14 mln. |
Geografische uitsplitsing van de verkoop: Abbott Laboratories
Start boekjaar: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
United States | 11,4 mld. | 13,02 mld. | 16,64 mld. | 18,14 mld. | 15,45 mld. |
All Other Countries | 11,53 mld. | 12,58 mld. | 15,52 mld. | 14,84 mld. | 14,08 mld. |
Germany | 1,75 mld. | 2,11 mld. | 2,57 mld. | 2,34 mld. | 2,34 mld. |
China | 2,35 mld. | 1,96 mld. | 2,39 mld. | 2,13 mld. | 2,25 mld. |
India | 1,4 mld. | 1,32 mld. | 1,56 mld. | 1,65 mld. | 1,75 mld. |
Switzerland | 1,07 mld. | 1,14 mld. | 1,31 mld. | 1,34 mld. | 1,64 mld. |
Japan | 1,44 mld. | 1,39 mld. | 1,7 mld. | 1,93 mld. | 1,51 mld. |
The Netherlands | 975 mln. | 1,08 mld. | - | - | 1,07 mld. |
Canada | - | - | 1,38 mld. | 1,28 mld. | - |
Uitvoerend comité: Abbott Laboratories
Bedrijfsleider | Titel | Leeftijd | Van |
---|---|---|---|
Robert Ford
CEO | Algemeen Directeur | 51 | 31-03-2020 |
Philip Boudreau
DFI | Financieel Directeur/CFO | 52 | 01-09-2023 |
Scott House
CTO | Hoofd Techniek/Wetenschap/O&O | - | 01-03-2020 |
Melissa Brotz
SAM | Verkoop & Marketing | - | - |
John McCoy
AUD | Comptroller/Controller/Auditor | 55 | 01-09-2023 |
Samenstelling van de raad van bestuur: Abbott Laboratories
Directeur | Titel | Leeftijd | Van |
---|---|---|---|
Robert Alpern
BRD | Directeur/Bestuurslid | 74 | 10-10-2008 |
Sally Blount
BRD | Directeur/Bestuurslid | 63 | 09-12-2011 |
Nancy McKinstry
BRD | Directeur/Bestuurslid | 66 | 09-12-2011 |
Daniel Starks
BRD | Directeur/Bestuurslid | 70 | 16-02-2017 |
John Stratton
BRD | Directeur/Bestuurslid | 64 | 29-06-2017 |
Robert Ford
CHM | Voorzitter | 51 | 10-12-2021 |
Michelle Kumbier
BRD | Directeur/Bestuurslid | 58 | 08-06-2018 |
Darren McDew
BRD | Directeur/Bestuurslid | 64 | 09-09-2019 |
Michael Roman
BRD | Directeur/Bestuurslid | 65 | 23-04-2021 |
Paola Gonzalez
BRD | Directeur/Bestuurslid | 53 | 30-08-2021 |
Participaties: Abbott Laboratories
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ABBOTT INDIA LIMITED 74,99% | 15 934 048 | 74,99% | 4 809 882 801 $ |
17 949 800 | 51,69% | 59 407 915 $ | |
ALLERGY THERAPEUTICS PLC 2,98% | 142 136 143 | 2,98% | 12 363 002 $ |
ALLERGY THERAPEUTICS PLC 4,74% | 2 061 855 | 4,74% | 2 694 741 $ |
Bedrijfsgegevens: Abbott Laboratories

Bedrijven van de groep: Abbott Laboratories
Naam | Categorie en sector |
---|---|
TwistDx Ltd.
![]() TwistDx Ltd. BiotechnologyHealth Technology Part of Abbott Laboratories, TwistDx Ltd. is a British company that specializes in recombinase polymerase amplification technology. The company is based in Maidenhead, UK. The company offers TwistAmp research kits for researchers to develop tests, assays, and kits relevant to their work in fields such as water testing, biodefense, food species verification, and clinical or veterinary diagnostics. The company can work with partners on specific assay development collaborations for research and commercial applications. The company offers devices and accessories for research and development use only. The company was founded in 2002 by Niall Armes, Derek Stemple, Nagesh K. Mahanthappa. |
Biotechnology
|
Abbott Laboratories Vascular Enterprises Ltd.
![]() Abbott Laboratories Vascular Enterprises Ltd. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Laboratories Vascular Enterprises Ltd. is an Irish company that manufactures medical devices. |
Medical Specialties
|
Abbott Laboratórios do Brasil Ltda.
![]() Abbott Laboratórios do Brasil Ltda. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratórios do Brasil Ltda. is a company based in São Paulo, Brazil. The Brazilian company conducts innovative research and develops products for human health at all stages of life. Recently, Abbott has launched new products that have the power to change lives. The company's website includes a privacy policy that outlines the definition, collection, and use of personal information. Learn more about Abbott, the personal health company. |
Pharmaceuticals: Major
|
Abbott Laboratories de Chile Ltda.
![]() Abbott Laboratories de Chile Ltda. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Laboratories de Chile Ltda. The company is based in Las Condes, Chile. is a Chilean company that engages in diagnostics, medical devices, nutritional, and branded generic medicines. |
Medical Specialties
|
Abbott Overseas Luxembourg SARL
![]() Abbott Overseas Luxembourg SARL Financial ConglomeratesFinance Part of Abbott Laboratories, Abbott Overseas Luxembourg SARL is a company that provides investment services. The company is based in Luxembourg, Luxembourg. |
Financial Conglomerates
|
Medische apparatuur, benodigdheden & distributie - Andere
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Varia. 1j. | Varia. 3j. | Kapi.($) | |
---|---|---|---|---|---|---|
-0,26% | -1,02% | +11,54% | +11,40% | 227 mld. | ||
-6,71% | -5,21% | +0,70% | -14,05% | 119 mld. | ||
-0,36% | -2,44% | -6,96% | -15,19% | 64,55 mld. | ||
-1,08% | -2,61% | +3,42% | +69,83% | 47,05 mld. | ||
-0,88% | +0,16% | +1,93% | +22,96% | 43,83 mld. | ||
+1,59% | +5,12% | -22,96% | -4,73% | 34,8 mld. | ||
-0,34% | +0,50% | +2,08% | +48,61% | 27,39 mld. | ||
-0,52% | -2,38% | -4,88% | -3,53% | 21,55 mld. | ||
-1,20% | -2,74% | -19,40% | -37,73% | 21,27 mld. | ||
+1,27% | +2,93% | -18,48% | -15,82% | 20,01 mld. | ||
Gemiddelde | -0,84% | -0,07% | -5,30% | +6,17% | 62,6 mld. | |
Gewogen gemiddelde per kap. | -1,48% | +0,68% | +1,38% | +6,70% |
Sector
